《2016年欧洲心脏病学会急慢性心力衰竭诊断与治疗指南》非药物治疗部分解读
张健,邹长虹
摘要(Abstract)：
<正>在2016年5月召开的欧洲心力衰竭年会上,欧洲心脏病学会(ESC)正式颁布了《2016年ESC急慢性心力衰竭诊断与治疗指南》(以下简称《2016年指南》)[1]。该指南是在《ESC急慢性心力衰竭诊断与治疗指南2012》(以下简称《2012年指南》[2]基础上,结合最新研究证据,进行广泛讨论后制定的。本文重点介绍与心力衰竭介入治疗相关的内容。在射血分数降低的心力衰竭(heart failure with
关键词(KeyWords)： 心力衰竭;起搏器;心肌梗死
基金项目(Foundation):
作者(Author): 张健,邹长虹
参考文献(References)：
- [1]Ponikowski P,Voors AA,Anker SD,et al.2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Society(ESC),developed with the special contribution of the Heart Failure Association(HFA)of the ESC.Eur J Heart Fail,2016,18(8):891-975.
- [2]Mc Murray JJ,Adamopoulos S,Anker SD,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure2012:The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardioloogy.Developed in collaboration with the Heart Failure Association(HFA)of the ESC.Eur J Heart Fail,2012,14(8):803-869.
- [3]Moss AJ,Schuger C,Beck CA,et al.Reduction in inappropriate therapy and mortality through ICD programming.N Engl J Med,2012,367(24):2275-2283.
- [4]Gasparini M,Proclemer A,Klersy C,et al.Effect of longdetection interval vs standard-detection interval for ICD on antitachycardia pacing and shock delivery:the ADVANCEⅢrandomized clinical trial.JAMA,2013,309(18):1903-1911.
- [5]Yap SC,Schaer BA,Bhagwandien RE,et al.Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy.Heart,2014,100(15):1188-1192.
- [6]Burke MC,Gold MR,Knight BP,et al.Safety and efficacy of the totally subcutaneous implantable defibrillator:2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry.J Am Coll Cardiol,2015,65(16):1605-1615.
- [7]Opreanu M,Wan C,Singh V,et al.Wearable cardioverterdefibrillator as a bridge to cardiac transplantation:a national database analysis.J Heart Lung Transplant,2015,34(10):1305-1309.
- [8]Steffel J,Robertson M,Singh JP,et al.The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex:asubgroup analysis of the Echo CRT trial.Eur Heart J,2015,36(30):1983-1989.
- [9]Kadish A,Nademanee K,Volosin K,et al.A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.Am Heart J,2011,161(2):329-337.e1-e2.
- [10]Singh JP,Kandala J,Camm AJ.Non-pharmacological modulation of the autonomic tone to treat heart failure.Eur Heart J,2014,35(2):77-85.
- [11]Ganesan AN,Nandal S,Lüker J,et al.Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment:a systematic review of efficacy and effect on ejection fraction.Heart Lung Circ,2015,24(3):270-280.
- [12]Reardon MJ,Adams DH,Kleiman NS,et al.2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement.J Am Coll Cardiol,2015,66(2):113-121.